Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumonectomy | 34 | 2023 | 1094 | 4.390 |
Why?
|
Tracheal Neoplasms | 16 | 2021 | 124 | 3.570 |
Why?
|
Thoracic Surgical Procedures | 10 | 2019 | 342 | 2.670 |
Why?
|
Esophagectomy | 19 | 2022 | 447 | 2.090 |
Why?
|
Lung Neoplasms | 36 | 2023 | 13096 | 1.780 |
Why?
|
Thoracic Surgery | 11 | 2019 | 719 | 1.680 |
Why?
|
Esophageal Neoplasms | 16 | 2022 | 1582 | 1.310 |
Why?
|
Tracheal Stenosis | 7 | 2021 | 226 | 1.290 |
Why?
|
Societies, Medical | 14 | 2019 | 3741 | 1.160 |
Why?
|
Respiratory Paralysis | 2 | 2016 | 31 | 1.150 |
Why?
|
Thoracic Surgery, Video-Assisted | 8 | 2023 | 273 | 1.080 |
Why?
|
Recurrent Laryngeal Nerve | 2 | 2016 | 139 | 1.040 |
Why?
|
Diaphragm | 2 | 2016 | 348 | 1.020 |
Why?
|
Thymectomy | 2 | 2015 | 192 | 0.950 |
Why?
|
Thoracic Wall | 3 | 2019 | 203 | 0.920 |
Why?
|
Mediastinal Neoplasms | 4 | 2018 | 421 | 0.880 |
Why?
|
Postoperative Complications | 29 | 2022 | 15294 | 0.860 |
Why?
|
Solitary Pulmonary Nodule | 3 | 2020 | 265 | 0.850 |
Why?
|
Laryngeal Neoplasms | 5 | 2010 | 512 | 0.830 |
Why?
|
Tracheal Diseases | 5 | 2007 | 113 | 0.790 |
Why?
|
Databases, Factual | 17 | 2021 | 7730 | 0.760 |
Why?
|
Respiration | 2 | 2016 | 1651 | 0.710 |
Why?
|
Biomedical Research | 4 | 2019 | 3311 | 0.710 |
Why?
|
Tracheostomy | 2 | 2021 | 400 | 0.680 |
Why?
|
Laryngectomy | 4 | 2010 | 248 | 0.660 |
Why?
|
Intubation, Intratracheal | 6 | 2021 | 1357 | 0.660 |
Why?
|
Trachea | 8 | 2012 | 1075 | 0.580 |
Why?
|
Carcinoma, Adenoid Cystic | 6 | 2019 | 252 | 0.580 |
Why?
|
Postoperative Hemorrhage | 1 | 2020 | 412 | 0.550 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 8 | 2022 | 5221 | 0.530 |
Why?
|
Bronchial Neoplasms | 5 | 2006 | 112 | 0.530 |
Why?
|
Tracheoesophageal Fistula | 3 | 2018 | 129 | 0.480 |
Why?
|
Pleural Neoplasms | 4 | 2020 | 607 | 0.480 |
Why?
|
Esophagus | 8 | 2012 | 1018 | 0.460 |
Why?
|
Anemia, Hemolytic | 1 | 2014 | 168 | 0.450 |
Why?
|
Registries | 4 | 2017 | 8090 | 0.450 |
Why?
|
Neoplasm Staging | 15 | 2022 | 11007 | 0.440 |
Why?
|
Pneumonia | 2 | 2023 | 2134 | 0.440 |
Why?
|
Pulmonary Veno-Occlusive Disease | 2 | 2013 | 66 | 0.440 |
Why?
|
Anastomosis, Surgical | 10 | 2021 | 987 | 0.440 |
Why?
|
Angiography | 1 | 2018 | 1638 | 0.420 |
Why?
|
Retrospective Studies | 51 | 2023 | 77426 | 0.420 |
Why?
|
Myasthenia Gravis | 1 | 2014 | 201 | 0.410 |
Why?
|
Neoadjuvant Therapy | 7 | 2019 | 2726 | 0.400 |
Why?
|
Muscle, Skeletal | 4 | 2020 | 4935 | 0.390 |
Why?
|
Bronchial Diseases | 3 | 2005 | 151 | 0.390 |
Why?
|
Pulmonary Artery | 1 | 2019 | 1912 | 0.370 |
Why?
|
Esophagitis | 3 | 2003 | 152 | 0.360 |
Why?
|
Airway Obstruction | 5 | 2010 | 663 | 0.360 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2014 | 601 | 0.360 |
Why?
|
Carcinoma, Squamous Cell | 11 | 2019 | 4033 | 0.350 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 658 | 0.350 |
Why?
|
Humans | 133 | 2023 | 744220 | 0.350 |
Why?
|
Deglutition Disorders | 5 | 2017 | 605 | 0.330 |
Why?
|
Esophageal Diseases | 4 | 2008 | 166 | 0.320 |
Why?
|
Treatment Outcome | 36 | 2022 | 63119 | 0.320 |
Why?
|
Reoperation | 7 | 2021 | 4203 | 0.300 |
Why?
|
Respiratory Tract Fistula | 1 | 2007 | 26 | 0.300 |
Why?
|
Patient Selection | 4 | 2019 | 4216 | 0.300 |
Why?
|
Granular Cell Tumor | 1 | 2007 | 51 | 0.300 |
Why?
|
Male | 90 | 2021 | 350027 | 0.300 |
Why?
|
Esophageal Perforation | 3 | 2022 | 69 | 0.300 |
Why?
|
Cutaneous Fistula | 1 | 2007 | 78 | 0.290 |
Why?
|
Thyroidectomy | 2 | 2010 | 879 | 0.290 |
Why?
|
Survival Rate | 17 | 2021 | 12781 | 0.290 |
Why?
|
Middle Aged | 73 | 2022 | 213367 | 0.290 |
Why?
|
Aged | 66 | 2022 | 163253 | 0.290 |
Why?
|
Quality Improvement | 7 | 2019 | 3746 | 0.290 |
Why?
|
Female | 87 | 2021 | 380197 | 0.270 |
Why?
|
Bronchoscopy | 5 | 2021 | 862 | 0.270 |
Why?
|
Bronchi | 3 | 2019 | 840 | 0.270 |
Why?
|
Sarcopenia | 2 | 2021 | 368 | 0.260 |
Why?
|
Thyroid Neoplasms | 2 | 2010 | 2281 | 0.260 |
Why?
|
Gastric Emptying | 2 | 2021 | 233 | 0.260 |
Why?
|
Esophageal Achalasia | 1 | 2006 | 91 | 0.260 |
Why?
|
Advisory Committees | 3 | 2018 | 774 | 0.260 |
Why?
|
Diverticulum | 1 | 2006 | 136 | 0.250 |
Why?
|
Pleura | 2 | 2020 | 235 | 0.250 |
Why?
|
Survival Analysis | 10 | 2021 | 10250 | 0.240 |
Why?
|
Thoracic Neoplasms | 1 | 2006 | 268 | 0.230 |
Why?
|
Thoracotomy | 5 | 2017 | 363 | 0.230 |
Why?
|
Mesothelioma | 1 | 2009 | 818 | 0.220 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2006 | 484 | 0.210 |
Why?
|
Stents | 4 | 2022 | 3280 | 0.210 |
Why?
|
Bronchial Fistula | 2 | 2018 | 85 | 0.210 |
Why?
|
Intussusception | 1 | 2003 | 115 | 0.210 |
Why?
|
Pulmonary Emphysema | 3 | 1996 | 672 | 0.210 |
Why?
|
Gastroesophageal Reflux | 3 | 2006 | 782 | 0.200 |
Why?
|
Adenocarcinoma | 11 | 2019 | 6352 | 0.200 |
Why?
|
Esophageal Stenosis | 3 | 2009 | 195 | 0.200 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2019 | 9230 | 0.190 |
Why?
|
Barrett Esophagus | 3 | 2011 | 494 | 0.190 |
Why?
|
Jejunum | 2 | 1993 | 480 | 0.190 |
Why?
|
Internship and Residency | 1 | 2021 | 5787 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 11 | 2022 | 20123 | 0.190 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2020 | 29 | 0.190 |
Why?
|
Follow-Up Studies | 14 | 2021 | 39045 | 0.180 |
Why?
|
Calcinosis | 1 | 2009 | 1499 | 0.180 |
Why?
|
Laryngostenosis | 2 | 2010 | 161 | 0.180 |
Why?
|
Solitary Fibrous Tumors | 1 | 2020 | 72 | 0.180 |
Why?
|
Adult | 45 | 2021 | 214035 | 0.170 |
Why?
|
Catheter Ablation | 2 | 2013 | 2758 | 0.170 |
Why?
|
Colon | 3 | 2008 | 1772 | 0.170 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2010 | 1770 | 0.170 |
Why?
|
Respiration Disorders | 1 | 2022 | 371 | 0.170 |
Why?
|
Gastric Outlet Obstruction | 2 | 2011 | 56 | 0.170 |
Why?
|
Pylorus | 2 | 2011 | 85 | 0.170 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2291 | 0.160 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2006 | 1380 | 0.160 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 1971 | 0.160 |
Why?
|
Lung Diseases | 2 | 2009 | 1885 | 0.160 |
Why?
|
Foramen Ovale, Patent | 1 | 2021 | 223 | 0.160 |
Why?
|
Preoperative Care | 2 | 2018 | 2246 | 0.160 |
Why?
|
Stomach | 2 | 2021 | 697 | 0.160 |
Why?
|
Diverticulum, Esophageal | 1 | 2017 | 13 | 0.160 |
Why?
|
RNA, Neoplasm | 1 | 2020 | 769 | 0.150 |
Why?
|
Thoracoscopy | 2 | 2017 | 178 | 0.150 |
Why?
|
Physician's Role | 1 | 2004 | 942 | 0.150 |
Why?
|
United States | 17 | 2022 | 69867 | 0.150 |
Why?
|
Biopsy | 2 | 2020 | 6757 | 0.140 |
Why?
|
Massachusetts | 4 | 2021 | 8663 | 0.140 |
Why?
|
Candidiasis | 1 | 1999 | 366 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2021 | 451 | 0.140 |
Why?
|
Forecasting | 2 | 2017 | 2949 | 0.140 |
Why?
|
Catheterization | 3 | 2011 | 1469 | 0.130 |
Why?
|
Neoplasm Invasiveness | 6 | 2020 | 3614 | 0.130 |
Why?
|
Neuromuscular Blockade | 1 | 2016 | 146 | 0.130 |
Why?
|
Aged, 80 and over | 23 | 2022 | 57768 | 0.130 |
Why?
|
Databases as Topic | 1 | 2017 | 475 | 0.130 |
Why?
|
Thoracic Diseases | 1 | 2016 | 97 | 0.130 |
Why?
|
Combined Modality Therapy | 7 | 2009 | 8628 | 0.130 |
Why?
|
Lung | 6 | 2022 | 9852 | 0.130 |
Why?
|
Consensus | 2 | 2021 | 2958 | 0.120 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1607 | 0.120 |
Why?
|
Hospital Mortality | 5 | 2012 | 5316 | 0.120 |
Why?
|
Necrosis | 4 | 2003 | 1643 | 0.120 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2016 | 320 | 0.120 |
Why?
|
Neoplasm Metastasis | 3 | 2019 | 4841 | 0.120 |
Why?
|
Length of Stay | 4 | 2020 | 6308 | 0.120 |
Why?
|
Ischemia | 1 | 2003 | 1914 | 0.120 |
Why?
|
Burns, Inhalation | 1 | 1993 | 33 | 0.120 |
Why?
|
Body Composition | 2 | 2020 | 2400 | 0.120 |
Why?
|
Muscle Weakness | 1 | 2016 | 415 | 0.120 |
Why?
|
Esophagogastric Junction | 2 | 2016 | 313 | 0.110 |
Why?
|
Forced Expiratory Volume | 5 | 2019 | 1744 | 0.110 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2013 | 13 | 0.110 |
Why?
|
Dyspnea | 4 | 2012 | 1303 | 0.110 |
Why?
|
Pulmonary Aspergillosis | 1 | 2013 | 47 | 0.110 |
Why?
|
Risk Factors | 13 | 2022 | 72280 | 0.110 |
Why?
|
Incidence | 4 | 2020 | 20945 | 0.110 |
Why?
|
Clinical Trials as Topic | 3 | 2011 | 7908 | 0.110 |
Why?
|
Solitary Fibrous Tumor, Pleural | 1 | 2012 | 25 | 0.110 |
Why?
|
Amyloidosis | 1 | 2020 | 795 | 0.110 |
Why?
|
Muscle Strength | 1 | 2016 | 592 | 0.110 |
Why?
|
Esophageal Fistula | 2 | 2003 | 64 | 0.100 |
Why?
|
Muscular Diseases | 1 | 2016 | 557 | 0.100 |
Why?
|
Hospital Costs | 1 | 2018 | 984 | 0.100 |
Why?
|
Carcinoma, Mucoepidermoid | 2 | 2019 | 88 | 0.100 |
Why?
|
Cardiac Surgical Procedures | 2 | 2018 | 3533 | 0.100 |
Why?
|
Fundoplication | 2 | 2017 | 138 | 0.100 |
Why?
|
Esophagoscopy | 2 | 2011 | 390 | 0.100 |
Why?
|
Atrial Fibrillation | 2 | 2013 | 5034 | 0.100 |
Why?
|
Silicones | 1 | 2012 | 250 | 0.100 |
Why?
|
Benchmarking | 1 | 2017 | 1042 | 0.090 |
Why?
|
Computer Simulation | 2 | 2021 | 6196 | 0.090 |
Why?
|
Tracheomalacia | 1 | 2010 | 63 | 0.090 |
Why?
|
Pleurodesis | 1 | 2010 | 41 | 0.090 |
Why?
|
Risk Assessment | 8 | 2018 | 23337 | 0.090 |
Why?
|
Risk Adjustment | 2 | 2017 | 594 | 0.090 |
Why?
|
Research | 1 | 2018 | 1999 | 0.090 |
Why?
|
General Surgery | 1 | 2021 | 1636 | 0.090 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2009 | 88 | 0.090 |
Why?
|
Cough | 3 | 2012 | 555 | 0.090 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2657 | 0.080 |
Why?
|
Echocardiography, Transesophageal | 2 | 2021 | 1132 | 0.080 |
Why?
|
Lung Diseases, Interstitial | 1 | 2017 | 808 | 0.080 |
Why?
|
Mediastinal Diseases | 1 | 2009 | 89 | 0.080 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 1199 | 0.080 |
Why?
|
Vena Cava, Superior | 1 | 2009 | 193 | 0.080 |
Why?
|
Esophagoplasty | 1 | 2008 | 43 | 0.080 |
Why?
|
Hemoptysis | 2 | 2010 | 155 | 0.080 |
Why?
|
Pleural Diseases | 1 | 2009 | 139 | 0.080 |
Why?
|
Embolization, Therapeutic | 1 | 2018 | 1392 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2020 | 3278 | 0.080 |
Why?
|
Microsatellite Instability | 1 | 2011 | 684 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8426 | 0.080 |
Why?
|
Lymph Node Excision | 2 | 2015 | 1256 | 0.070 |
Why?
|
Lymphangiosarcoma | 1 | 2006 | 13 | 0.070 |
Why?
|
Medical Audit | 1 | 2008 | 467 | 0.070 |
Why?
|
Lung Transplantation | 1 | 1996 | 1155 | 0.070 |
Why?
|
Sarcoma | 2 | 2011 | 1897 | 0.070 |
Why?
|
Patient Readmission | 1 | 2021 | 3114 | 0.070 |
Why?
|
Fatal Outcome | 2 | 2009 | 1849 | 0.070 |
Why?
|
Osteolysis, Essential | 1 | 2006 | 30 | 0.070 |
Why?
|
Gastric Fistula | 1 | 2007 | 73 | 0.070 |
Why?
|
Clinical Competence | 2 | 2020 | 4687 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2211 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2019 | 6535 | 0.070 |
Why?
|
Life Tables | 1 | 2006 | 370 | 0.070 |
Why?
|
Lymphatic Metastasis | 3 | 2015 | 2914 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2006 | 251 | 0.070 |
Why?
|
Adolescent | 14 | 2019 | 85759 | 0.070 |
Why?
|
Recurrence | 2 | 2009 | 8343 | 0.070 |
Why?
|
Time Factors | 8 | 2019 | 40063 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19907 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4477 | 0.070 |
Why?
|
Respiratory Sounds | 2 | 2010 | 696 | 0.060 |
Why?
|
Child | 12 | 2019 | 77679 | 0.060 |
Why?
|
Body Mass Index | 2 | 2019 | 12718 | 0.060 |
Why?
|
Hoarseness | 1 | 2005 | 65 | 0.060 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 2030 | 0.060 |
Why?
|
Laryngoscopy | 1 | 2010 | 706 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15538 | 0.060 |
Why?
|
Thymoma | 1 | 2005 | 186 | 0.060 |
Why?
|
Tracheotomy | 1 | 2004 | 166 | 0.060 |
Why?
|
Surgical Wound Dehiscence | 1 | 2004 | 215 | 0.060 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2009 | 555 | 0.060 |
Why?
|
Prognosis | 8 | 2020 | 29050 | 0.060 |
Why?
|
Stomach Neoplasms | 2 | 2011 | 1333 | 0.060 |
Why?
|
Thymus Neoplasms | 1 | 2005 | 268 | 0.060 |
Why?
|
Pulmonary Veins | 1 | 2009 | 761 | 0.050 |
Why?
|
Salivary Gland Neoplasms | 1 | 2006 | 298 | 0.050 |
Why?
|
Chondrosarcoma | 1 | 2005 | 309 | 0.050 |
Why?
|
Prospective Studies | 4 | 2021 | 53280 | 0.050 |
Why?
|
Early Detection of Cancer | 3 | 2022 | 3086 | 0.050 |
Why?
|
Morbidity | 2 | 2019 | 1769 | 0.050 |
Why?
|
Muscle, Smooth | 1 | 2006 | 934 | 0.050 |
Why?
|
Immunohistochemistry | 6 | 2020 | 11368 | 0.050 |
Why?
|
Chest Pain | 1 | 2009 | 1114 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1255 | 0.050 |
Why?
|
Child, Preschool | 6 | 2019 | 40992 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2010 | 3474 | 0.050 |
Why?
|
Device Removal | 1 | 2006 | 656 | 0.050 |
Why?
|
beta-Galactosidase | 2 | 1999 | 573 | 0.050 |
Why?
|
Radiography | 3 | 2009 | 7022 | 0.050 |
Why?
|
Anastomotic Leak | 1 | 2022 | 162 | 0.050 |
Why?
|
Neoplasms, Fibrous Tissue | 1 | 2001 | 25 | 0.050 |
Why?
|
Equipment Design | 2 | 2003 | 3582 | 0.050 |
Why?
|
Respiratory Function Tests | 3 | 2010 | 1618 | 0.050 |
Why?
|
Hospitals, General | 2 | 2017 | 749 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2016 | 11493 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12244 | 0.050 |
Why?
|
Papillomaviridae | 2 | 1999 | 1119 | 0.050 |
Why?
|
Cohort Studies | 7 | 2020 | 40559 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6893 | 0.040 |
Why?
|
Larynx | 1 | 2004 | 494 | 0.040 |
Why?
|
Perioperative Period | 1 | 2021 | 256 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12961 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2003 | 1107 | 0.040 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2003 | 312 | 0.040 |
Why?
|
Odds Ratio | 2 | 2009 | 9849 | 0.040 |
Why?
|
Palliative Care | 2 | 2006 | 3490 | 0.040 |
Why?
|
Papain | 1 | 1999 | 64 | 0.040 |
Why?
|
Chymotrypsin | 1 | 1999 | 149 | 0.040 |
Why?
|
Leiomyoma | 1 | 2005 | 730 | 0.040 |
Why?
|
Education, Medical, Continuing | 2 | 2017 | 840 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 548 | 0.040 |
Why?
|
Annual Reports as Topic | 1 | 2018 | 33 | 0.040 |
Why?
|
Mentors | 1 | 2004 | 630 | 0.040 |
Why?
|
Cocarcinogenesis | 3 | 1987 | 54 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 4586 | 0.040 |
Why?
|
Digestive System Neoplasms | 1 | 1999 | 87 | 0.040 |
Why?
|
Surgical Procedures, Operative | 2 | 2004 | 1875 | 0.040 |
Why?
|
Shoulder Fractures | 1 | 1999 | 88 | 0.040 |
Why?
|
Logistic Models | 2 | 2021 | 13409 | 0.040 |
Why?
|
Neurilemmoma | 1 | 2003 | 547 | 0.040 |
Why?
|
Shoulder Dislocation | 1 | 1999 | 122 | 0.040 |
Why?
|
Liposarcoma | 1 | 2001 | 333 | 0.040 |
Why?
|
Immunocompromised Host | 1 | 2003 | 847 | 0.040 |
Why?
|
Hair Follicle | 1 | 1999 | 209 | 0.040 |
Why?
|
Humerus | 1 | 1999 | 266 | 0.040 |
Why?
|
Patient Care Team | 1 | 2008 | 2529 | 0.040 |
Why?
|
Epidermal Growth Factor | 3 | 1998 | 709 | 0.040 |
Why?
|
Foreign-Body Migration | 1 | 1999 | 221 | 0.040 |
Why?
|
Carcinogens | 3 | 1989 | 466 | 0.040 |
Why?
|
Genotype | 1 | 2011 | 12956 | 0.040 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1999 | 358 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2016 | 35423 | 0.040 |
Why?
|
Oncogene Proteins, Viral | 1 | 1998 | 362 | 0.030 |
Why?
|
Radiotherapy | 1 | 2003 | 1525 | 0.030 |
Why?
|
Thorax | 1 | 1999 | 547 | 0.030 |
Why?
|
Total Lung Capacity | 1 | 1996 | 143 | 0.030 |
Why?
|
Anorexia | 1 | 2016 | 159 | 0.030 |
Why?
|
Organizational Innovation | 1 | 2018 | 559 | 0.030 |
Why?
|
Manometry | 1 | 2017 | 445 | 0.030 |
Why?
|
Paclitaxel | 2 | 2001 | 1707 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 1999 | 623 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2009 | 3047 | 0.030 |
Why?
|
Incidental Findings | 1 | 2019 | 689 | 0.030 |
Why?
|
Young Adult | 7 | 2019 | 56436 | 0.030 |
Why?
|
Cisplatin | 2 | 2016 | 1642 | 0.030 |
Why?
|
Models, Economic | 1 | 2018 | 713 | 0.030 |
Why?
|
Survivors | 1 | 2004 | 2291 | 0.030 |
Why?
|
Carcinoma | 1 | 2005 | 2375 | 0.030 |
Why?
|
Anticoagulants | 1 | 2009 | 4599 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 668 | 0.030 |
Why?
|
Cost Savings | 1 | 2018 | 926 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2003 | 1880 | 0.030 |
Why?
|
Camptothecin | 1 | 2016 | 576 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12355 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1993 | 821 | 0.030 |
Why?
|
Dimethylhydrazines | 2 | 1989 | 12 | 0.030 |
Why?
|
Dilatation | 1 | 1993 | 291 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 1996 | 1147 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1993 | 442 | 0.020 |
Why?
|
Cardia | 1 | 2011 | 57 | 0.020 |
Why?
|
Equipment Failure | 1 | 1994 | 579 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2022 | 3469 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 665 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 977 | 0.020 |
Why?
|
Pain | 1 | 2005 | 4987 | 0.020 |
Why?
|
Methylhydrazines | 1 | 1989 | 6 | 0.020 |
Why?
|
Nitrosamines | 2 | 1987 | 87 | 0.020 |
Why?
|
Colitis | 2 | 1989 | 1170 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2011 | 553 | 0.020 |
Why?
|
Leadership | 1 | 2018 | 1357 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15070 | 0.020 |
Why?
|
Age Factors | 3 | 2013 | 18367 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 3913 | 0.020 |
Why?
|
Transsexualism | 1 | 2012 | 178 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1831 | 0.020 |
Why?
|
Carcinoma, Large Cell | 1 | 2008 | 113 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4929 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2009 | 11728 | 0.020 |
Why?
|
Esophagitis, Peptic | 1 | 2008 | 78 | 0.020 |
Why?
|
Vital Capacity | 1 | 2010 | 926 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2011 | 1950 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 1993 | 1341 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6367 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3584 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 602 | 0.020 |
Why?
|
Vascular Patency | 1 | 2009 | 886 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 1999 | 5867 | 0.020 |
Why?
|
Spirometry | 1 | 2009 | 864 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3528 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3952 | 0.020 |
Why?
|
Carcinoma, Small Cell | 1 | 2008 | 420 | 0.020 |
Why?
|
Chylothorax | 1 | 2006 | 84 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2886 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5396 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 783 | 0.020 |
Why?
|
Colonic Neoplasms | 2 | 1989 | 2538 | 0.020 |
Why?
|
Polypropylenes | 1 | 2005 | 64 | 0.020 |
Why?
|
HIV Infections | 1 | 2012 | 16718 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3509 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2011 | 1039 | 0.020 |
Why?
|
Gastroscopy | 1 | 2006 | 207 | 0.020 |
Why?
|
Granulation Tissue | 1 | 2004 | 93 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3527 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1365 | 0.020 |
Why?
|
Infant | 2 | 2019 | 35129 | 0.020 |
Why?
|
Sutures | 1 | 1987 | 299 | 0.020 |
Why?
|
Perioperative Care | 1 | 2012 | 1000 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1993 | 2108 | 0.010 |
Why?
|
Precancerous Conditions | 1 | 2011 | 975 | 0.010 |
Why?
|
Oxygen | 1 | 1996 | 4187 | 0.010 |
Why?
|
Sex Factors | 2 | 2008 | 10396 | 0.010 |
Why?
|
Netherlands | 1 | 2008 | 2170 | 0.010 |
Why?
|
Laminectomy | 1 | 2003 | 234 | 0.010 |
Why?
|
Genes, Reporter | 2 | 1999 | 1547 | 0.010 |
Why?
|
Pancreatic Neoplasms | 3 | 1999 | 5257 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2008 | 804 | 0.010 |
Why?
|
Smoking | 2 | 2010 | 8986 | 0.010 |
Why?
|
Graft Survival | 1 | 1992 | 3740 | 0.010 |
Why?
|
Vitamin E | 1 | 1986 | 869 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2003 | 1161 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6172 | 0.010 |
Why?
|
Drainage | 1 | 2006 | 1141 | 0.010 |
Why?
|
Mice, Transgenic | 3 | 1999 | 9735 | 0.010 |
Why?
|
Transfection | 2 | 1999 | 5892 | 0.010 |
Why?
|
Vimentin | 1 | 2001 | 261 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 2003 | 599 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2727 | 0.010 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1987 | 802 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3036 | 0.010 |
Why?
|
Autopsy | 1 | 2003 | 1021 | 0.010 |
Why?
|
Iontophoresis | 1 | 1999 | 74 | 0.010 |
Why?
|
Regression Analysis | 1 | 2009 | 6461 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2009 | 1390 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2003 | 924 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2001 | 657 | 0.010 |
Why?
|
Boston | 1 | 2012 | 9311 | 0.010 |
Why?
|
Frozen Sections | 1 | 1999 | 155 | 0.010 |
Why?
|
1,2-Dimethylhydrazine | 2 | 1989 | 8 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1999 | 642 | 0.010 |
Why?
|
Transforming Growth Factor alpha | 1 | 1998 | 135 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2003 | 996 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 1999 | 317 | 0.010 |
Why?
|
Receptor, erbB-3 | 1 | 1998 | 142 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2003 | 1504 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2006 | 5076 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2005 | 1736 | 0.010 |
Why?
|
Mesocricetus | 2 | 1987 | 252 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1998 | 431 | 0.010 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 1996 | 116 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3508 | 0.010 |
Why?
|
Liposomes | 1 | 1999 | 758 | 0.010 |
Why?
|
Transgenes | 1 | 1999 | 1009 | 0.010 |
Why?
|
Mitosis | 1 | 2001 | 1208 | 0.010 |
Why?
|
Actins | 1 | 2003 | 2121 | 0.010 |
Why?
|
Gene Expression | 2 | 1999 | 7799 | 0.010 |
Why?
|
Neutropenia | 1 | 2001 | 895 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13280 | 0.010 |
Why?
|
Graft Rejection | 1 | 2008 | 4399 | 0.010 |
Why?
|
Drug Carriers | 1 | 1999 | 693 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1987 | 2237 | 0.010 |
Why?
|
HIV-1 | 1 | 2012 | 6938 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1998 | 2505 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10387 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2008 | 3336 | 0.010 |
Why?
|
Wound Healing | 1 | 2004 | 2785 | 0.010 |
Why?
|
Animals | 9 | 2003 | 168788 | 0.010 |
Why?
|
Models, Statistical | 1 | 2008 | 5102 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1993 | 878 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1993 | 286 | 0.010 |
Why?
|
Cricetinae | 2 | 1987 | 2472 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2003 | 2003 | 0.010 |
Why?
|
Mice | 6 | 1999 | 81178 | 0.010 |
Why?
|
Dexamethasone | 1 | 1999 | 1948 | 0.010 |
Why?
|
Reference Values | 1 | 1999 | 4982 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2001 | 2969 | 0.010 |
Why?
|
Receptors, Glucocorticoid | 1 | 1993 | 302 | 0.010 |
Why?
|
Ligands | 1 | 1998 | 3294 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 13885 | 0.010 |
Why?
|
Genetic Vectors | 1 | 1998 | 3420 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6612 | 0.000 |
Why?
|
Receptor, erbB-2 | 1 | 1998 | 2416 | 0.000 |
Why?
|
Animals, Newborn | 1 | 1993 | 2726 | 0.000 |
Why?
|
FANFT | 1 | 1987 | 1 | 0.000 |
Why?
|
Mutation | 1 | 2011 | 29784 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1999 | 3690 | 0.000 |
Why?
|
Cystitis | 1 | 1987 | 92 | 0.000 |
Why?
|
Phosphorylation | 1 | 1998 | 8437 | 0.000 |
Why?
|
Rats | 1 | 2003 | 24273 | 0.000 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 1986 | 180 | 0.000 |
Why?
|
Free Radicals | 1 | 1986 | 236 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1998 | 10949 | 0.000 |
Why?
|
Acetylcysteine | 1 | 1987 | 272 | 0.000 |
Why?
|
Proto-Oncogene Proteins | 1 | 1998 | 4553 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2003 | 18027 | 0.000 |
Why?
|
Cell Line | 1 | 1998 | 15999 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1986 | 1827 | 0.000 |
Why?
|
Base Sequence | 1 | 1993 | 12801 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1999 | 21824 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1993 | 18116 | 0.000 |
Why?
|
Oncogenes | 1 | 1986 | 1265 | 0.000 |
Why?
|
Skin | 1 | 1993 | 4363 | 0.000 |
Why?
|
Cell Division | 1 | 1986 | 4567 | 0.000 |
Why?
|
Receptors, Cell Surface | 1 | 1986 | 2867 | 0.000 |
Why?
|
Body Weight | 1 | 1986 | 4666 | 0.000 |
Why?
|
Quality of Life | 1 | 1996 | 12805 | 0.000 |
Why?
|
Diet | 1 | 1986 | 7937 | 0.000 |
Why?
|